TRAWS PHARMA, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.6207 USD | -1.87% |
|
-7.36% | -16.75% |
| 04/04 | North American Morning Briefing : Focus Turns to -2- | DJ |
| 04/04 | Traws Pharma, Inc. Announces Chief Executive Office Changes | CI |
Chart calendar Traws Pharma, Inc.
835.ooEYEmTTPUBuCSJfW2nZeiFzZjJafFLqDy4GMIDhDGU.2LFfWSrnZyEDMRsJMjjqO3YUNncAJQbed3FWW8SFdAHstVx7LKUQdwBoSQ~4653e35bb2ad4e03db51d60d21e28cb3
Upcoming events on Traws Pharma, Inc.
Past events on Traws Pharma, Inc.
| 08/04/2024 09:30 pm | American Association for Cancer Research Meeting |
| 02/04/2024 06:00 pm | Onconova Therapeutics, Inc. and Trawsfynydd Therapeutics, Inc. Merger Call |
| 01/04/2024 | Q4 2023 Earnings Release |
| 12/12/2023 07:30 am | American Society of Hematology Meeting - Poster Number: 4181 |
| 08/12/2023 | San Antonio Breast Cancer Conference |
| 04/12/2023 09:00 pm | Noble Capital Markets Emerging Growth Equity Conference |
| 15/11/2023 03:00 am | Q3 2023 Earnings Call |
| 15/11/2023 02:35 am | Q3 2023 Earnings Release |
| 12/10/2023 07:30 pm | European Academy of Dermatology and Venereology Conference - Session:D2T01.3 |
| 07/10/2023 | European MCL Network Meeting |
| 11/09/2023 04:30 pm | H.C. Wainwright Global Investment Conference |
| 11/08/2023 02:00 am | Q2 2023 Earnings Call |
| 11/08/2023 01:35 am | Q2 2023 Earnings Release |
| 10/08/2023 06:30 pm | Annual General Meeting - Reconvened |
| 21/07/2023 06:30 pm | Annual General Meeting |
| 17/06/2023 | International Conference on Malignant Lymphoma |
| 03/06/2023 | American Society of Clinical Oncology Conference |
| 18/05/2023 08:30 pm | Ladenburg Thalmann Virtual R&D Showcase |
| 16/05/2023 02:00 am | Q1 2023 Earnings Call |
| 16/05/2023 01:48 am | Q1 2023 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 2,18 2,21 -1.01% | 0,23 0,20 12.86% | 0,23 0,23 -2.59% | 0,23 0,21 8.92% | 0,23 0,22 4.96% | 0,21 |
|
EBITDA Million USD | Released Forecast Spread | -21,7 -22,4 3.19% | -25,0 -25,3 1.26% | -16,5 -18,6 11.39% | -19,6 -19,7 0.44% | -20,3 0,00 - | -23,5 |
|
EBIT Million USD | Released Forecast Spread | -21,7 -21,9 1.04% | -25,0 -24,4 -2.51% | -16,5 -17,5 5.83% | -19,6 -20,0 1.82% | -20,3 -21,2 4.36% | -23,5 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -21,5 -21,7 0.84% | -25,2 -24,3 -3.32% | -16,2 -17,0 4.99% | -19,0 -19,8 4% | -18,9 -20,5 7.68% | -23,3 |
|
Net income Million USD | Released Forecast Spread | -21,5 -21,7 0.8% | -25,2 -24,3 -3.34% | -16,2 -17,0 4.99% | -19,0 -19,8 4% | -18,9 -20,5 7.68% | -23,3 |
|
EPS USD | Released Forecast Spread | -22,3 -12,1 -85.09% | -2,10 -2,05 -2.44% | -0,96 -0,92 -4.35% | -0,91 -0,93 1.62% | -0,90 -0,96 5.92% | -0,87 |
| Announcement Date | 24/03/20 | 11/03/21 | 17/03/22 | 16/03/23 | 01/04/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,06 0,06 -5.88% | 0,06 0,08 -29.11% | 0,06 0,06 -0.44% | 0,06 0,07 -22.63% | 0,06 0,06 -10.4% | 0,06 0,08 -29.11% | 0,06 0,07 -17.69% | 0,06 0,07 -17.69% | 0,06 0,07 -14.28% | 0,06 | 0,06 | 0,06 | 0,06 |
|
EBITDA Million USD | Released Forecast Spread | -3,76 -5,90 36.29% | -4,13 -3,90 -5.87% | -4,12 -4,30 4.28% | -5,64 -4,40 -28.14% | -5,73 -5,80 1.21% | -6,13 -5,80 -5.76% | -6,20 | -5,08 -5,50 7.56% | -4,46 | ||||
|
EBIT Million USD | Released Forecast Spread | -3,76 -4,26 11.65% | -4,13 -4,17 0.97% | -4,12 -4,46 7.62% | -5,64 -4,62 -22.23% | -5,73 -6,29 8.85% | -6,14 -6,67 7.96% | -4,61 -6,82 32.36% | -5,09 -6,57 22.56% | -4,46 -5,51 19.06% | ||||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -3,76 -4,61 18.39% | -4,12 -4,05 -1.82% | -4,02 -4,34 7.28% | -5,40 -4,51 -19.69% | -5,42 -6,06 10.57% | -5,78 -6,28 8.02% | -4,25 -6,51 34.72% | -4,74 -6,47 26.77% | -4,18 -5,21 19.64% | ||||
|
Net income Million USD | Released Forecast Spread | -3,76 -4,61 18.39% | -4,12 -4,05 -1.82% | -4,02 -4,34 7.28% | -5,40 -4,51 -19.69% | -5,42 -6,06 10.57% | -5,78 -6,28 8.02% | -4,25 -6,51 34.72% | -4,74 -6,47 26.77% | -4,18 -5,21 19.64% | ||||
|
EPS USD | Released Forecast Spread | -0,16 -0,27 40.74% | -0,20 -0,19 -6.67% | -0,19 -0,20 3.8% | -0,26 -0,21 -22.35% | -0,26 -0,28 6.31% | -0,28 -0,30 5.88% | -0,20 -0,31 36% | -0,23 -0,29 20.69% | -0,20 -0,25 21.05% | -0,23 | -0,25 | -0,28 | -0,29 |
| Announcement Date | 17/03/22 | 11/05/22 | 11/08/22 | 14/11/22 | 16/03/23 | 15/05/23 | 10/08/23 | 14/11/23 | 01/04/24 | - | - | - | - |
| Today 01:35 am | QIAGEN N.V.: Q1 2024 Earnings Release |
| 30/04/2024 | CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | AZENTA, INC.: Q2 2024 Earnings Release (Projected) |
| 01/05/2024 04:00 pm | UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release |
| 01/05/2024 04:00 pm | BIO-TECHNE CORPORATION: Q3 2024 Earnings Release |
| 01/05/2024 04:30 pm | ALKERMES PLC: Q1 2024 Earnings Release |
| 02/05/2024 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
Past sector events for Traws Pharma, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- TRAW Stock
- Calendar Traws Pharma, Inc.
